| | A comparative cohort study was conducted on COVID 19 samples from two different variants Daxing B.1.1.7 and Shunyi B.1.470, to determine the clinical freatures of B.1.1.7 variant. 7 clinical features-fever, C-reactive protein, d-dimmer, serum Amyloid A, creative kinase, CD4+ T lymphocyte and ground glass opacity was more in the Daxing group (B.1.1.7) when compared to the Shunyi B.1.470 group | Limitations of this study are - 1. Small sample size of the two groups and 2. Clinical feature of B.1.1.7 variant was not compared with SARS-COV2 variant other than B.1.470. ✍ | Pre-print ( medRXiv )
| Date of Publishing | 2021 May 08 | | Title | COVID-19 cases from the first local outbreak of SARS-CoV-2 B.1.1.7 variant in China presented more serious clinical features: a prospective, comparative cohort study | | Impact factor | N/A | | Date of Entry | 2021 Jul 2 |
|